Catalyst Wire Dossier Catalyst Wire Dossier

B/F/TAF triple regimen

bictegravir/emtricitabine/tenofovir alafenamide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for B/F/TAF triple regimen, covering 2019-08-13 to 2019-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating Inflammatory and Immunological Changes of HIV-positive Patients Switching to DTG Dual Regimen Compared to Those Switching to a Triple Drugs Regimen (B/F/TAF) [Phase 4]

See pricing